Top Ten Cancer Statistics

1. Childhood cancer is the leading cause of death by disease among children in the United States.

2. Every day, 36 children are diagnosed with cancer.

3. The average age of diagnosis is 6.

4. Cancer affects all ethnic, gender, and socio-economic groups.

5. More than 40,000 children undergo treatment for cancer each year.

6. One out of 5 children who are diagnosed with cancer do not survive.

7. 3 out of 5 children who survive, suffer devastating late effects such as secondary cancers, muscular difficulties and infertility.

8. In the last 40 years, the overall survival rate for children’s cancer has increased from 10% to more than 80%, but for many more rare childhood cancers, the survival rate is much less.

9. There are approximately 350,000 adult survivors of children’s cancer in the United States.

10. Every year, 13,500 parents hear the words “your child has cancer.”

For more children’s cancer information, visit CureSearch.org.

Day in the Life: Teri Freeman

Teri Freeman is a Birmingham CureSearch Walk committee member. Her daughter, Bekah, was diagnosed with osteosarcoma when she was 12 years old. Since then, Teri has become an advocate for children with cancer, telling anyone who will listen about the importance of increased funding and awareness.

Teri Freeman

Q:  What lead you to CureSearch?

A:  My daughter was diagnosed with osteosarcoma when she was 12. When she was diagnosed we wanted to gather every bit of information that we could. After seeing what children with cancer go through, the lack of funding, and the outdated treatments, I knew that I had to find a way to give back. I heard about CureSearch while at the hospital one day, and knew that it was perfect for me.

Q: What lead you to becoming a CureSearch Walk Committee Member?

A:  I followed CureSearch through the years and when I received an email about the first Birmingham Walk, I jumped on board. The first year, I signed up for the Walk, but couldn’t attend, my daughter attended the Walk on my behalf, and now is involved with CureSearch as well.  Last year, I signed up to be a committee member, fundraise  and spread the word as much as possible. This year I am on the committee again!

I will tell anyone about the importance of helping children with cancer. A lot of people are weary of donating, but I like to remind them that the money is going to help children like my daughter. Even if they can’t come to the Walk, they can donate or be a virtual walker. Even something small can make a big difference. The Walk gives me a way to tell others about something that I am passionate about.

Q: What is the hardest part of being a Walk committee member?

A:  Knowing how much more funding is needed to advance treatments can be discouraging, but I always tell myself that every little bit counts. It is also hard to get people to talk about children’s cancer. It’s a hard topic for people to discuss, but once I present them with the facts, they are much more eager to get involved. I like to remind people that I wasn’t a cancer mom until the day that my daughter was diagnosed.

Q: What is your favorite part of the CureSearch Walk?

A:  Seeing the children thriving is the best part. Knowing that the money that I helped raise is going to make better treatment for them is an amazing feeling. The day is all about celebrating the progress we have made, but also recognizing how much more we have to do.

Six Important Questions About Childhood Cancer

Dr. Lisa DIller

Lisa Diller, MD, chief medical officer at Dana-Farber/Boston Children’s Cancer and Blood Disorders Center, was asked to answer these important questions.

What signs might lead a child’s pediatrician to suspect cancer?

Cancer is very diverse, and diagnosis is further complicated because many signs and symptoms—like fever, bruising and headaches—are normal in healthy children.

Pediatricians are extremely skilled at distinguishing the usual bumps and pains from the concerning ones. They sense which symptoms truly need evaluation and astutely order tests based on the character, duration and severity of symptoms—and oftentimes their own instinct—to properly diagnose children.

What advice do you have for parents whose child has been diagnosed with cancer?

For most pediatric cancers, parents should remain positive. Cure rates have been steadily improving.

For instance, nearly 90 percent of children with standard acute lymphoblastic leukemia (ALL), the most common form of pediatric cancer, are cured with current therapy, and the long-term cure rate for Hodgkin lymphoma is 97 percent. The five-year survival rate for all childhood cancers combined is 83 percent, up from 58 percent in the mid-1970s. Many families have experience with cancer in elderly adult relatives,  and it’s important to keep in mind the good prognosis in children.

Read more…

$5 Million in Grants Awarded to Researchers Studying Children’s Cancer

CureSearch for Children’s Cancer this week announced the recipients of its Acceleration Initiative grants, awarding $5 million to children’s cancer researchers studying areas critical to achieving breakthroughs in treatments and with the potential to reach patients in early clinical trials within three years. New treatments are important because 40,000 children undergo cancer treatment each year, and cancer remains the leading cause of death by disease in children.

“Working with our Scientific Advisory Council, we identified three grand challenges that represent research barriers that need to be overcome in order to truly advance the field and create a lasting impact for kids with cancer,” says Laura Thrall, president and CEO of CureSearch. “We are thrilled to be funding research with patient-centric outcomes that not only addresses unmet needs but also uses innovative and novel approaches to do so.”

The first ‘grand challenge’ invited investigators to develop novel approaches to treating metastatic disease (when cancer spreads to new locations in the body), with the potential for broad applicability to multiple cancers and/or patient populations, that have a high probability of clinical application within 3 years.

Read more…

Why Painting Tumors Could Make Brain Surgeons Better

Tumor Paint

(NPR.org) – September 12, 2013: Perhaps one of the most uncomfortable things a doctor has to tell patients is that their medical problems are iatrogenic. What that means is they were caused by a doctor in the course of the treatment.

Sometimes these iatrogenic injuries are accidental. But sometimes, because of the limits of medical technology, they can be inevitable. Now, a medical researcher in Seattle thinks he has a way to eliminate some of the inevitable ones.

James Olson is a physician at the Seattle Children’s Hospital, where he primarily takes care of kids with brain cancer. He’s also a cancer researcher at the Fred Hutchinson Cancer Research Center in Seattle.

MRI reveals the location of a brain tumor. But it’s one thing to see the tumor in a scan, quite another to find the tumor in a living brain. Olson says that today, surgeons splay open the brain in an effort to find exactly where the tumor is.

Just doing that can cause problems. And the surgeons can’t always tell tumor cells from healthy brain cells, so inevitably the thorough doctors remove some healthy cells too.

Read more…

Day in the Life: Dr. Kolb

dr kolb 3

E. Anders Kolb, MD is a pediatric oncologist at Nemours/ Alfred I. duPont Hospital for Children in Wilmington, Delaware. Dr. Kolb Goes MOM on Cancer every day striving to provide his patients with the best possible care. He loves getting to know his patients and their families and will stop at nothing to be the best doctor he can.  CureSearch recently caught up with him to learn more about why he chose pediatric oncology medicine.

Q:  What drew you to pediatric oncology?

A:  I have always felt a passion for science and medicine, but I was drawn to pediatric oncology because of the highly personal care that is given to each patient and family. I enjoy getting to know patients on a personal level, while guiding them through the challenging experience of
cancer diagnosis and treatment.

Q:  What is the hardest part of being a doctor?

A:  When I have to deliver bad news, it breaks my heart. I try to make it as comforting as possible and help patients and families get through the experience. Sharing bad news in a manner that is understandable and informative is imperative. It is also very difficult. But, these experiences have molded me as a physician and person and I am grateful to all my patients and their families for that.

Q:  What is your favorite part of working in pediatric oncology?

A:  Whenever I talk to people outside of the cancer world, they remark on how difficult it must be to work with children. While I agree that it is challenging, the joy that I get from taking care of kids is immeasurable. I believe that how we take care of our kids is a real reflection of who we are as a society, so I try to give the best care I can, every day.

I had one patient in particular who wanted to go skydiving. We had to pull a lot of strings to put together the trip, but we were able to in the end with a lot of help from the community. I was a surprised and a bit scared when he asked me to go with him. In the end I decided to go. The courage he showed every day in fighting his cancer was nothing compared to the courage I needed to fall from a plane. Our children push us in ways that are unexpected and amazing.

Gene for most common childhood cancer identified

stained ALL leukemia bone marrow cells

An aberrant gene has been found to cause the most common childhood cancer in the world, pre-B cell acute lymphoblastic leukemia or ALL.

The gene, PAX5, has long been known to be involved in ALL. The new study indicates a mutation in the gene alone is sufficient to eventually cause the disease. ALL affects nearly 3,000 children and teenagers in the United States each year.

The discovery should make it possible to screen for the gene in families with a history of the disease and suggests new strategies for treating the disease, said Dr. Marshall Horwitz, professor of pathology and of medicine at the University of Washington. He is a co-author of the new study.

He was joined in the study by researchers at St. Jude Children’s Research Hospital in Memphis, Tennessee led by Dr. Charles Mullighan; Memorial Sloan-Kettering Cancer Center in New York City led by Dr. Kenneth Offit, and others at the UW. The results were published Sept. 8 in the journal Nature Genetics.

Read more